Impact of COVID19 pandemic on treatment outcome of locally-advanced head and neck squamous cell carcinoma (LA-HNSCC): IMPACCT study.

被引：0
|
作者：
Guillen Sentis, Pau
Castillo Manzano, Carmen
Quiros, Beatriz
Morey Cortes, Francisca
Tous, Sara
Plana, Maria
Brenes Castro, Jesus
Lozano, Alicia
Linares, Isabel
Vilajosana Altamis, M. Esther
Gomez Garcia, Victoria
Labori Trias, Maria
Goma, Montse
Mari Roig, Antonio
Bermejo, Oriol
Tornero Salto, Jordi
Taberna, Miren
Alemany, Laia
Mesia, Ricard
Oliva Bernal, Marc
机构：
[1] Inst Catala Oncol, Barcelona, Spain
[2] Inst Catala Oncol, Lhospitalet De Llobregat, Spain
[3] Catalan Inst Oncol, IDIBELL, Barcelona, Spain
[4] Inst Invest Biomed Bellvitge IDIBELL ICO, Lhospitalet De Llobregat, Spain
[5] Catalan Inst Oncol, Dept Med Oncol, Lhospitalet De Llobregat, Barcelona, Spain
[6] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain
[7] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain
[8] Inst Catala Invest Biomed Bellvitge IDIBELL, Inst Catala Oncol Hosp, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.6061
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6061
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 "PembroRad" randomized trial
    Bourhis, J.
    Sire, C.
    Tao, Y.
    Martin, L.
    Alfonsi, M.
    Prevost, J. B.
    Rives, M.
    Lafond, C.
    Tourani, J. M.
    Biau, J.
    Geoffrois, L.
    Coutte, A.
    Liem, X.
    Vauleon, E.
    Drouet, F.
    Pechery, A.
    Guigay, J.
    Wanneveich, M.
    Auperin, A.
    Sun, X.
    ANNALS OF ONCOLOGY, 2020, 31 : S1168 - S1168
  • [32] Response-Adapted Volume Deescalation (RAVD) in Locally Advanced Head and Neck Squamous Cell Cancer (LA-HNSCC): Toxicity and Quality of Life (QOL) Analyses
    Melotek, J. M.
    Villaflor, V. M.
    Brisson, R. J.
    Karrison, T. G.
    Blair, E. A.
    Portugal, L.
    Stenson, K. M.
    De Souza, J.
    Cohen, E.
    Langerman, A.
    Spiotto, M. T.
    Seiwert, T.
    Vokes, E. E.
    Haraf, D. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E335 - E335
  • [33] Toxicity of Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma Treatment
    Torres, S.
    Sargento, I.
    Ferreira, M.
    Oliveira, J. O. A. O.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S552 - S552
  • [34] Clinical Outcome of Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Won, Hye Sung
    Lee, Youn Soo
    Jeon, Eun Kyoung
    Hong, Sook Hee
    Kang, Jin-Hyoung
    Kim, Yeon-Sil
    Yoo, Le Ryung
    Sun, Dong-Il
    Kim, Min-Sik
    ANTICANCER RESEARCH, 2014, 34 (10) : 5709 - 5714
  • [35] Multi-institution Analysis of Concurrent Chemoradiation Therapy With Cisplatin (CDDP) Versus Cetuximab (C225) in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LA-HNSCC): Can HPV Help Decide Which Agent?
    Riaz, N.
    Baschnagel, A.
    Adkins, D.
    Rao, S.
    Huang, J.
    Chen, P.
    Ley, J.
    Krauss, D.
    Thorstad, W.
    Lee, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S78 - S79
  • [36] Effect of induction chemotherapy (IC) on survival in locally advanced head and neck squanums cell carcinoma (LA-HNSCC) treated with chemoradiotherapy: Single center experience.
    Ock, Chan-Young
    Keam, Bhumsuk
    Kim, Tae Min
    Lee, Se-Hoon
    Hah, J. Hun
    Kwon, Tack-Kyun
    Kim, Dong-Wan
    Wu, Hong-Gyun
    Sung, Myung-Whun
    Heo, Dae Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] A Phase II Study of Definitive Radiation Therapy With Concurrent Erlotinib and Docetaxel in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)
    Woods, C. R.
    Yao, M.
    Rezaee, R.
    Zender, C.
    Hsu, D.
    Fu, P.
    Wasman, J.
    Machtay, M.
    Lavertu, P.
    Savvides, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S507 - S508
  • [38] Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy (CCRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A randomized controlled multi-centered trial
    He, X.
    Yin, H.
    Guo, W.
    Sun, X.
    Hu, X.
    Yan, P.
    Li, F.
    Huang, S.
    Zhou, H.
    Zhang, F.
    Wang, B.
    Bian, X.
    Wei, Q.
    Wu, J.
    Wang, F.
    Song, D.
    Liu, J.
    Zhou, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] Retrospective analysis of the addition of cetuximab to induction chemotherapy (IC) with docetaxel, cisplatin, and 5-fluorouracil (TPF-C) for locally advanced squamous cell carcinoma of the head and neck (LA-HNSCC)
    Kuperman, D. I.
    Nussenbaum, B.
    Thorstad, W.
    Haughey, B.
    Lewis, J.
    Adkins, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC).
    Uppaluri, Ravindra
    Zolkind, Paul
    Lin, Tianxiang
    Nussenbaum, Brian
    Jackson, Ryan S.
    Rich, Jason
    Pipkorn, Patrik
    Paniello, Randal
    Thorstad, Wade
    Michel, Loren
    Mudianto, Tenny
    Oppelt, Peter John
    Wildes, Tanya Marya
    Dunn, Gavin P.
    Piccirillo, Jay F.
    Kallogjeri, Donna
    Rodig, Scott
    Hagemann, Ian S.
    Chernock, Rebecca
    Adkins, Douglas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345